PUBLISHER: Lucintel | PRODUCT CODE: 1416293
PUBLISHER: Lucintel | PRODUCT CODE: 1416293
The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-
Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.
Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in COVID-19 testing, POC infectious disease testing, and others.
North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.
Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).
Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
Q1. What is the infectious disease diagnostics market size?
Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.
Q2. What is the growth forecast for infectious disease diagnostics market?
Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?
Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.
Q4. What are the major segments for infectious disease diagnostics market?
Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.
Q5. Who are the key infectious disease diagnostics market companies?
Answer: Some of the key infectious disease diagnostics companies are as follows:
Q6. Which infectious disease diagnostics market segment will be the largest in future?
Answer: Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.
Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.